Noidak (Isotretinoin)

Isotretinoin, the active ingredient in Noidak, is a retinoid presented as an oral dosage form for systemic use. It is indicated for the treatment of severe nodular acne and refractory acne vulgaris in patients who have not responded to conventional therapies.

GNH USA supplies Noidak as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU GMP standards and provides regulatory documentation for global distribution.

Isotretinoin is a systemic retinoid used in dermatology for severe acne conditions.

- Severe nodular acne: reduces lesion count and prevents new nodule formation. - Refractory acne vulgaris: achieves clearance in patients unresponsive to other treatments. - Severe cystic acne: improves skin texture and decreases inflammatory lesions.

Isotretinoin may cause a range of adverse reactions, varying from common to serious.

Common Side Effects: - Dry skin and mucous membranes. - Cheilitis (cracked lips). - Dry eyes and ocular irritation. - Epistaxis (nosebleeds). - Joint or muscle aches. - Headache.

Serious or Rare Side Effects: - Severe depression, suicidal ideation, or psychosis. - Pancreatitis. - Inflammatory bowel disease. - Severe hypertriglyceridemia. - Pseudotumor cerebri (intracranial hypertension). - Hepatotoxicity with marked elevation of liver enzymes.

Before initiating therapy, clinicians should evaluate several safety considerations.

- Pregnancy: contraindicated due to high teratogenic risk (Category X). - Laboratory monitoring: regular liver function and lipid profile assessments are recommended. - Concomitant vitamin A: avoid because of additive toxicity. - Psychiatric symptoms: monitor for depression or mood changes. - Sun exposure: advise use of sunscreen and protective clothing. - Store at ambient temperature below 25°C: keep in the original container, protect from moisture and light.

Isotretinoin interacts with several medicines; some should be avoided while others require close monitoring.

Major Interactions (Avoid): - Tetracycline antibiotics: may reduce isotretinoin efficacy. - Vitamin A supplements: increase risk of toxicity. - Systemic corticosteroids: raise risk of pseudotumor cerebri. - Phenobarbital and other enzyme inducers: lower isotretinoin plasma levels. - Oral contraceptives: may have reduced effectiveness.

Moderate Interactions (Monitor Closely): - Azithromycin: may elevate liver enzymes. - Topical retinoids: increase skin irritation. - Anticoagulants (e.g., warfarin): possible alteration of INR. - Diuretics: may exacerbate hyperuricemia. - Antihypertensives: monitor for additive hypotensive effects.